Biovica International AB Income Statement

Financials in millions SEK. Fiscal year is May - April.

Millions SEK. Fiscal year is May - Apr.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Apr '26 Apr 30, 2026	Apr '25 Apr 30, 2025	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023	Apr '22 Apr 30, 2022
Revenue	15.1	10.96	8.3	5.7	6.3
Revenue Growth (YoY)	37.76%	32.00%	45.80%	-9.55%	-29.08%
Cost of Revenue	1.13	0.54	0.41	0.34	0.37
Gross Profit	13.96	10.43	7.89	5.36	5.93
Selling, General & Admin	75.09	85.63	123.52	106.69	59.35
Depreciation & Amortization Expenses	8.3	8.84	9.43	8.21	6.44
Other Operating Expenses	0.7	1.79	1.79	0.91	0.24
Total Operating Expenses	84.08	96.27	134.74	115.81	66.03
Operating Income	-70.12	-85.84	-126.85	-110.46	-60.1
Interest Income	1.01	1	3	0.27	0.19
Interest Expense	-0.4	-1.14	-0.29	-0.49	-0.08
Total Non-Operating Income (Expense)	0.61	-0.14	2.71	-0.22	0.11
Pretax Income	-69.51	-85.98	-124.14	-110.68	-59.99
Provision for Income Taxes	-0.35	-1.64	-0.69	0.19	-0.01
Net Income	-69.16	-84.34	-123.45	-110.87	-59.98
Net Income to Common	-69.86	-87.62	-124.82	-110.49	-60
Shares Outstanding (Basic)	235	93	58	35	28
Shares Outstanding (Diluted)	235	93	58	35	28
Shares Change (YoY)	153.64%	58.49%	67.70%	22.40%	-2.26%
EPS (Basic)	-0.30	-0.95	-2.14	-3.17	-2.11
EPS (Diluted)	-0.30	-0.95	-2.14	-3.17	-2.11
Free Cash Flow	-63.28	-85.65	-114.72	-95.85	-52.53
Free Cash Flow Per Share	-0.27	-0.93	-1.96	-2.75	-1.85
Gross Margin	92.49%	95.12%	95.03%	94.03%	94.11%
Operating Margin	-464.43%	-783.21%	-1527.70%	-1939.56%	-954.59%
Profit Margin	-458.05%	-769.54%	-1486.80%	-1946.74%	-952.65%
FCF Margin	-419.13%	-781.51%	-1381.68%	-1682.99%	-834.37%
EBITDA	-61.82	-77	-117.42	-102.24	-53.66
EBITDA Margin	-409.49%	-702.53%	-1414.14%	-1795.33%	-852.32%
EBIT	-70.12	-85.84	-126.85	-110.46	-60.1
EBIT Margin	-464.43%	-783.21%	-1527.70%	-1939.56%	-954.59%
Effective Tax Rate	0.51%	1.91%	0.55%	-0.17%	0.02%